Related Experiment Videos
Myeloma kidney: pathogenesis and treatment
N Basić-Jukić1, P Kes, B Labar
1Department of Medicine, Zagreb University Hospital Center, Kispatićeva 12, 10000 Zagreb, Croatia. nina-basic@net.hr
Summary
Multiple myeloma often causes kidney failure due to light chain issues and dehydration. Treatments involve chemotherapy, stem cell transplant, and supportive care to manage myeloma kidney.
Area of Science:
- Nephrology
- Hematology
- Oncology
Background:
- Renal failure is a common and serious complication in multiple myeloma patients.
- The development of myeloma kidney is influenced by light chain excretion, its biochemical properties, and volume status.
Purpose of the Study:
- To outline the pathogenetic mechanisms of myeloma kidney.
- To review current and experimental therapeutic strategies for managing renal complications in multiple myeloma.
Main Methods:
- Review of existing literature on myeloma kidney pathogenesis and treatment.
- Categorization of therapeutic interventions into standard and experimental approaches.
Main Results:
- Two primary mechanisms contribute to myeloma kidney: direct tubular toxicity and intratubular cast formation.
- Therapeutic options include chemotherapy, stem cell transplantation, plasmapheresis, dialysis, and management of hypercalcemia and anemia.
Conclusions:
- Effective management of myeloma kidney requires addressing light chain excretion, toxicity, and cast formation.
- A multi-faceted approach combining standard treatments, supportive care, and avoidance of nephrotoxins is crucial for improving outcomes in multiple myeloma patients with renal impairment.